ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,921,000 | +409.5% | 468,455 | +343.6% | 0.00% | – |
| Q4 2021 | $377,000 | -64.5% | 105,593 | -63.8% | 0.00% | -100.0% |
| Q3 2021 | $1,063,000 | -48.3% | 291,901 | -38.1% | 0.00% | 0.0% |
| Q2 2021 | $2,055,000 | +6.5% | 471,254 | +0.4% | 0.00% | 0.0% |
| Q1 2021 | $1,930,000 | +684.6% | 469,476 | +662.6% | 0.00% | – |
| Q4 2020 | $246,000 | +223.7% | 61,561 | +118.8% | 0.00% | – |
| Q3 2020 | $76,000 | -94.4% | 28,140 | -94.3% | 0.00% | -100.0% |
| Q2 2020 | $1,353,000 | -54.2% | 491,974 | -60.7% | 0.00% | -71.4% |
| Q1 2020 | $2,953,000 | -63.3% | 1,251,352 | -26.9% | 0.01% | -30.0% |
| Q4 2019 | $8,046,000 | +16662.5% | 1,711,963 | +11796.1% | 0.01% | – |
| Q3 2019 | $48,000 | -94.1% | 14,391 | -94.7% | 0.00% | -100.0% |
| Q1 2019 | $816,000 | -80.1% | 269,471 | -82.1% | 0.00% | -83.3% |
| Q4 2018 | $4,102,000 | +76.7% | 1,507,964 | +118.2% | 0.01% | +100.0% |
| Q3 2018 | $2,322,000 | +10957.1% | 691,166 | +6361.9% | 0.00% | – |
| Q4 2017 | $21,000 | -93.3% | 10,696 | -89.0% | 0.00% | – |
| Q3 2017 | $315,000 | -75.2% | 97,372 | -75.3% | 0.00% | -100.0% |
| Q2 2017 | $1,269,000 | -79.5% | 394,251 | -81.9% | 0.00% | -81.8% |
| Q1 2017 | $6,202,000 | +311.8% | 2,183,784 | +237.9% | 0.01% | +266.7% |
| Q4 2016 | $1,506,000 | -7.9% | 646,256 | -33.6% | 0.00% | 0.0% |
| Q3 2016 | $1,635,000 | +22.1% | 973,442 | -23.7% | 0.00% | 0.0% |
| Q2 2016 | $1,339,000 | -48.8% | 1,275,595 | -41.0% | 0.00% | -40.0% |
| Q4 2015 | $2,615,000 | +346.2% | 2,161,249 | +526.9% | 0.01% | +400.0% |
| Q3 2015 | $586,000 | -68.3% | 344,772 | -61.2% | 0.00% | -75.0% |
| Q2 2015 | $1,846,000 | +68.3% | 887,846 | +119.3% | 0.00% | +100.0% |
| Q1 2015 | $1,097,000 | -3.1% | 404,882 | -8.0% | 0.00% | 0.0% |
| Q4 2014 | $1,132,000 | -82.0% | 440,320 | -87.2% | 0.00% | -87.5% |
| Q3 2014 | $6,297,000 | -42.0% | 3,440,975 | -15.4% | 0.02% | -46.7% |
| Q2 2014 | $10,860,000 | +38.1% | 4,067,481 | +81.0% | 0.03% | +30.4% |
| Q1 2014 | $7,863,000 | -17.9% | 2,246,616 | +4.8% | 0.02% | -23.3% |
| Q4 2013 | $9,583,000 | +6894.9% | 2,143,399 | +6235.4% | 0.03% | – |
| Q3 2013 | $137,000 | – | 33,832 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 4,598,329 | $10,852,000 | 4.99% |
| Soleus Capital Management, L.P. | 864,100 | $2,039,000 | 2.37% |
| Healthcare Value Capital, LLC | 500,000 | $1,180,000 | 1.98% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,227,114 | $2,896,000 | 0.86% |
| PERKINS CAPITAL MANAGEMENT INC | 232,166 | $548,000 | 0.66% |
| Stonepine Capital Management, LLC | 151,189 | $357,000 | 0.38% |
| Zebra Capital Management LLC | 84,963 | $200,000 | 0.32% |
| Intrinsic Edge Capital Management LLC | 1,000,000 | $2,360,000 | 0.31% |
| Alambic Investment Management, L.P. | 46,069 | $109,000 | 0.26% |
| OBERWEIS ASSET MANAGEMENT INC/ | 200,600 | $473,000 | 0.26% |